GENTIAN DIAGNOSTICS ASA GENT Innsidehandel

Mandatory notification of transaction - merger of Obligasjon 2 AS into Kvantia AS

17. November 2026 kl. 15:54

Moss, 17 November 2026

Gentian Diagnostics ASA ("Gentian") has today been notified of the following transaction: Obligasjon 2 AS has been merged into Kvantia AS, with Kvantia AS as the surviving company. As a result, the 85,000 shares in Gentian held by Obligasjon 2 AS have been transferred to Kvantia AS. The transfer took place as part of the merger without any cash consideration, and the shares are therefore reported at a price of NOK 0 per share.

Following the transaction, Obligasjon 2 AS owns no shares in Gentian. Kvantia AS owns 1,888,368 shares in Gentian, about 12.2% of the total outstanding shares. The transaction is an internal restructuring within the group, and it does not change the group's combined holding. Kvantia AS, Caaby AS, Norda ASA, Insr ASA, Finyield AS and Victoria India Fund AS together hold 3,586,358 shares in Gentian, about 23.2% of the total outstanding shares.

Christian Åbyholm is a Member of the Board of Directors of Kvantia AS and is a Member of the Board of Directors and primary insider in Gentian.

PCA notification pursuant to the EU Market Abuse Regulation Article 19 is attached. This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act, EU Market Abuse Regulation Article 19 and Euronext Oslo Rule Book II.

For further information, please contact:

Njaal Kind Group CFO njaal.kind@gentian.no +47 91 90 65 25

Vedlegg

PDF
KRT-1500 Kvantia fusjon med OBL2.pdf